SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027266
Filing Date
2022-11-14
Accepted
2022-11-14 16:10:01
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20220930_10q.htm   iXBRL 10-Q 770895
2 EXHIBIT 31.1 ex_444897.htm EX-31.1 9047
3 EXHIBIT 31.2 ex_444898.htm EX-31.2 8921
4 EXHIBIT 32.1 ex_444899.htm EX-32.1 4772
5 EXHIBIT 32.2 ex_444900.htm EX-32.2 5151
11 image01.jpg GRAPHIC 6181
  Complete submission text file 0001437749-22-027266.txt   3799896

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20220930.xsd EX-101.SCH 38709
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20220930_cal.xml EX-101.CAL 24546
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20220930_def.xml EX-101.DEF 243965
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20220930_lab.xml EX-101.LAB 232807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20220930_pre.xml EX-101.PRE 268248
51 EXTRACTED XBRL INSTANCE DOCUMENT dffn20220930_10q_htm.xml XML 522716
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 221385271
SIC: 2834 Pharmaceutical Preparations